U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. ByPro Nutrition, LLC - 646308 - 11/30/2023
  1. Warning Letters

CLOSEOUT LETTER

ByPro Nutrition, LLC MARCS-CMS 646308 —

Delivery Method:
Via Email
Product:
Dietary Supplements
Recipient:
Recipient Name
Robert L Bynum
Recipient Title
Owner
ByPro Nutrition, LLC

1906 Potomac Dr
Columbia, MO 65203-5843
United States

dr.bynum@bypronutrition.com
Issuing Office:
Division of Human and Animal Food Operations West II

United States

Dear Mr. Bynum:

The Food and Drug Administration has completed an evaluation of ByPro Nutrition, LLC corrective actions in response to our Warning Letter (CMS case #: 646308) on April 4, 2023. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.


Sincerely,
/S/
LaTonya M. Mitchell, Ph.D.
Program Division Director,
Office of Human and Animal Food Operations,
West Division II

Back to Top